INSMED Inc (28)
Browse by Contract Category
Contracts
-
Sales Agreement, dated as of February 25 2021, between SVB Leerink LLC and Insmed Incorporated
(Filed With SEC on February 25, 2021)
-
Form of Award Agreement for Restricted Stock Units issued to directors pursuant to the Insmed Incorporated 2019 Incentive Plan
(Filed With SEC on February 25, 2021)
-
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on February 25, 2021)
-
License Agreement, dated April 25, 2008, between Transave, Inc. and PARI Pharma GmbH, and Amendments No. 1-4 thereto
(Filed With SEC on October 29, 2020)
-
Underwriting Agreement, dated May 4, 2020, by and between Insmed Incorporated and SVB Leerink LLC, as representative of the underwriters named in Schedule I thereto
(Filed With SEC on May 7, 2020)
-
Second Amendment to Lease, dated October 17, 2018, between CIP II/AR Bridgewater Holdings LLC and Insmed Incorporated
(Filed With SEC on May 7, 2019)
-
Form of Award Agreement for Non-Qualified Stock Options pursuant to the Insmed Incorporated 2019 Incentive Plan
(Filed With SEC on February 25, 2021)
-
Form of Award Agreement for Restricted Stock Units pursuant to the Insmed Incorporated 2019 Incentive Plan
(Filed With SEC on February 25, 2021)
-
Omnibus Amendment to Insmed Incorporated Incentive Plans, dated December 10, 2020
(Filed With SEC on February 25, 2021)
-
Amending Agreement, dated March 13, 2014, between Insmed Incorporated and Therapure Biopharma Inc
(Filed With SEC on October 29, 2020)
-
Contract Manufacturing Agreement, dated February 7, 2014, between Insmed Incorporated and Therapure Biopharma Inc
(Filed With SEC on October 29, 2020)
-
Second Amendment to Employment Agreement, effective as of July 31, 2019, between Insmed Incorporated and S. Nicole Schaeffer
(Filed With SEC on April 30, 2020)
-
Employment Agreement, effective as of January 28, 2020, between Insmed Incorporated and Sara Bonstein
(Filed With SEC on February 25, 2020)
-
Employment Agreement, effective as of March 17, 2014, between Insmed Incorporated and John Goll
(Filed With SEC on February 25, 2020)
-
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on February 25, 2020)
-
Second Amendment to Employment Agreement, effective as of July 31, 2019, between Insmed Incorporated and Christine Pellizzari
(Filed With SEC on August 1, 2019)
-
Amendment to Employment Agreement, effective as of July 31, 2019, between Insmed Incorporated and Roger Adsett
(Filed With SEC on August 1, 2019)
-
Amendment to Employment Agreement, effective as of July 31, 2019, between Insmed Incorporated and William H. Lewis
(Filed With SEC on August 1, 2019)
-
Form of Award Agreement for Restricted Stock Units issued to directors pursuant to the Insmed Incorporated 2019 Incentive Plan
(Filed With SEC on August 1, 2019)
-
Form of Non-Qualified Stock Option Agreement under the Insmed Incorporated 2019 Incentive Plan
(Filed With SEC on August 1, 2019)
-
Form of Restricted Unit Award Agreement under the Insmed Incorporated 2019 Incentive Plan
(Filed With SEC on August 1, 2019)
-
Insmed Incorporated 2019 Incentive Plan
(Filed With SEC on August 1, 2019)
-
Underwriting Agreement, dated May 21, 2019, by and among Insmed Incorporated, William H. Lewis and Morgan Stanley & Co. LLC, SVB Leerink LLC and Goldman Sachs & Co. LLC, as...
(Filed With SEC on May 24, 2019)
-
Separation Agreement and General Release between Insmed Incorporated and Paolo Tombesi, dated as of May 3, 2019
(Filed With SEC on May 7, 2019)
-
First Amendment to Lease, dated October 1, 2016, between CIP II/AR Bridgewater Holdings LLC and Insmed Incorporated
(Filed With SEC on May 7, 2019)
-
Form of Award Agreement for Restricted Stock Units issued to directors pursuant to the Insmed Incorporated 2017 Incentive Plan
(Filed With SEC on May 7, 2019)
-
Extension of Commercial Fill/Finish Services Agreement between Insmed Incorporated and Ajinomoto Althea, Inc., dated as of December 18, 2018
(Filed With SEC on February 22, 2019)
-
Amendment No. 8 to License Agreement between Insmed Incorporated and PARI Pharma GmbH, effective as of December 19, 2018
(Filed With SEC on February 22, 2019)